EP1501870A4 - RSV PROTEINS, ANTIBODIES, COMPOSITIONS, METHODS AND USES - Google Patents

RSV PROTEINS, ANTIBODIES, COMPOSITIONS, METHODS AND USES

Info

Publication number: EP1501870A4
Authority: EP; European Patent Office
Prior art keywords: antibodies; compositions; methods; rsv proteins; rsv
Prior art date: 2001-11-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP02806688A

Other languages

German (de)

French (fr)

Other versions

EP1501870A2 (en

Inventor

Bernard Scallon

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Janssen Biotech Inc

Original Assignee

Centocor Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-02

Filing date

2002-10-26

Publication date

2006-05-03

2002-10-26 Application filed by Centocor Inc filed Critical Centocor Inc

2005-02-02 Publication of EP1501870A2 publication Critical patent/EP1501870A2/en

2006-05-03 Publication of EP1501870A4 publication Critical patent/EP1501870A4/en

Status Withdrawn legal-status Critical Current

Classifications

- C07K16/11—
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Tropical Medicine & Parasitology (AREA)
Virology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

EP02806688A 2001-11-02 2002-10-26 RSV PROTEINS, ANTIBODIES, COMPOSITIONS, METHODS AND USES Withdrawn EP1501870A4 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US33608101P	2001-11-02	2001-11-02
US336081P		2001-11-02
US33783801P	2001-11-13	2001-11-13
US337838P		2001-11-13
PCT/US2002/034154 WO2003063767A2 (en)	2001-11-02	2002-10-26	Rsv proteins, antibodies, compositions, methods and uses

Publications (2)

Publication Number	Publication Date
EP1501870A2 EP1501870A2 (en)	2005-02-02
EP1501870A4 true EP1501870A4 (en)	2006-05-03

Family

ID=27668884

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP02806688A Withdrawn EP1501870A4 (en)	2001-11-02	2002-10-26	RSV PROTEINS, ANTIBODIES, COMPOSITIONS, METHODS AND USES

Country Status (6)

Country	Link
EP (1)	EP1501870A4 (en)
JP (1)	JP2005522996A (en)
AU (1)	AU2002365925A1 (en)
CA (1)	CA2466025A1 (en)
MX (1)	MXPA04004224A (en)
WO (1)	WO2003063767A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1176195T3 (en)	1999-04-09	2013-06-24	Kyowa Hakko Kirin Co Ltd	Method for controlling the activity of immunologically functional molecule
US6946292B2 (en)	2000-10-06	2005-09-20	Kyowa Hakko Kogyo Co., Ltd.	Cells producing antibody compositions with increased antibody dependent cytotoxic activity
DK1698640T4 (en)	2003-10-01	2019-09-02	Kyowa Hakko Kirin Co Ltd	PROCEDURE FOR STABILIZING ANTIBODY AND ANTIBODY PREPARATION AS A STABILIZED SOLUTION.
JP5575377B2 (en)	2008-07-18	2014-08-20	シスメックス株式会社	RS virus detection kit and immunochromatography test device using anti-RS virus monoclonal antibody, and novel anti-RS virus monoclonal antibody

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5840298A (en) *	1995-06-07	1998-11-24	Idec Pharmaceuticals Corporation	Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
WO2001064751A2 (en) *	2000-03-01	2001-09-07	Medimmune, Inc.	High potency recombinant antibodies and method for producing them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2191016T3 (en) *	1992-09-16	2003-09-01	Scripps Research Inst	HUMAN NEUTRALIZING MONOCLONAL ANTIBODIES FOR THE SYNCTIAL RESPIRATORY VIRUS.
EP0977590A4 (en) *	1996-11-01	2001-03-14	Smithkline Beecham Corp	HUMAN MONOCLONAL ANTIBODIES

2002
- 2002-10-26 EP EP02806688A patent/EP1501870A4/en not_active Withdrawn
- 2002-10-26 JP JP2003563463A patent/JP2005522996A/en active Pending
- 2002-10-26 CA CA002466025A patent/CA2466025A1/en not_active Abandoned
- 2002-10-26 AU AU2002365925A patent/AU2002365925A1/en not_active Abandoned
- 2002-10-26 WO PCT/US2002/034154 patent/WO2003063767A2/en not_active Ceased
- 2002-10-26 MX MXPA04004224A patent/MXPA04004224A/en not_active Application Discontinuation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5840298A (en) *	1995-06-07	1998-11-24	Idec Pharmaceuticals Corporation	Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
WO2001064751A2 (en) *	2000-03-01	2001-09-07	Medimmune, Inc.	High potency recombinant antibodies and method for producing them

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BARBAS CARLOS F III ET AL: "Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 89, no. 21, 1992, pages 10164 - 10168, XP002369927, ISSN: 0027-8424 *

Also Published As

Publication number	Publication date
EP1501870A2 (en)	2005-02-02
MXPA04004224A (en)	2005-03-31
AU2002365925A1 (en)	2003-09-02
JP2005522996A (en)	2005-08-04
WO2003063767A2 (en)	2003-08-07
CA2466025A1 (en)	2003-08-07
WO2003063767A3 (en)	2004-12-02

Publication	Publication Date	Title
EP1562968A4 (en)	2006-08-23	ANTI-IL-6 ANTIBODIES, COMPOSITIONS, METHODS AND USES THEREOF
EP1396500A4 (en)	2005-02-02	ANTI-TRAIL-R ANTIBODIES
EP1660638A4 (en)	2009-02-18	LIPOPARTICLES COMPRISING PROTEINS, AND METHODS OF MAKING AND USING SAME LIPOPARTICLES
CY2019029I1 (en)	2020-05-29	ANTI-TNF ANTIBODIES, COMPOSITIONS, METHODS AND USES
EP1536828A4 (en)	2006-01-18	METHODS OF DISTRIBUTING EXTENDED CYTOSOL PROTEINS AND USES THEREOF
EP1423431A4 (en)	2005-04-27	ANTI-VLA-1 ANTIBODIES
EP1551877A4 (en)	2006-01-18	ANTI-TACI ANTIBODIES AND USES THEREOF
EP1572881A4 (en)	2007-06-13	TACI AND BR3 POLYPEPTIDES AND USES THEREOF
DK1390389T3 (en)	2009-04-20	Crypto-blocking antibodies and uses thereof
EP1517724A4 (en)	2005-12-14	ANTI-ANGIOGENIC PROTEINS, THEIR FRAGMENTS AND METHODS OF USE
EP1581641A4 (en)	2006-11-15	COMPOSITIONS, SPLICE VARIANTS AND METHODS RELATING TO OVARY SPECIFIC GENES AND PROTEINS
MA27035A1 (en)	2004-12-20	5-HT RECEPTOR LIGANDS AND USES THEREOF
NO20032587L (en)	2003-07-31	ABCA-1 student connections
MA30684B1 (en)	2009-09-01	ANTI-MN ANTIBODIES AND METHODS OF USE THEREOF
EP1616881A4 (en)	2008-08-27	ANTI-MPL ANTIBODIES
DE60239403D1 (en)	2011-04-21	ELECTROMECHANIC MICROSENSOR
BR0209242A (en)	2004-06-15	Starch functional aminopolidiorganosiloxanes
EP1812062A4 (en)	2012-12-19	ANTI-ADDL ANTIBODIES AND USES THEREOF
EP1435946A4 (en)	2006-02-01	LINKED BIARYL CONNECTIONS
EP1378520A4 (en)	2006-08-16	CYCLIC MONOCATARY TRISPECIFIC ANTIBODY
EP1294513A4 (en)	2005-11-23	LOCALIZATION-SPECIFIC COVALENTS BIOKON JUGATION OF PROTEINS
EP1542721A4 (en)	2007-05-02	MODIFIED "S" ANTIBODIES
EP1699485A4 (en)	2007-12-19	ANTI-HYDROXYLASE ANTIBODIES AND USES
DE60332711D1 (en)	2010-07-08	NEW INSECTICIDES PROTEINS FROM BAZILLUS THURINGIENSIS
PT1439818E (en)	2005-03-31	LYSIN CONTENT MASTIGAVEL COMPRESSED

Legal Events

Date	Code	Title	Description
2004-12-17	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2005-02-02	17P	Request for examination filed	Effective date: 20040601
2005-02-02	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
2005-02-02	AX	Request for extension of the european patent	Extension state: AL LT LV MK RO SI
2006-05-03	A4	Supplementary search report drawn up and despatched	Effective date: 20060320
2006-08-09	17Q	First examination report despatched	Effective date: 20060706
2007-04-06	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2007-05-09	18D	Application deemed to be withdrawn	Effective date: 20061117